Paste your Google Webmaster Tools verification code here
Yes, you hear it right. The miracle technology that has long been used for “tuning in” (inserting new genes) and “dropping out” (knocking out genes), has now gained scientists confidence “turning on” genes, which earlier had little potency. The older technique had demonstrated only limited success in activating specific genes. However, a new CRISPR/Cas9 approach is capable of activating genes more effectively than older approaches.
The new approach may allow scientists to more easily determine the function of individual genes, according to Feng Zhang, Ph.D., a researcher at MIT and the Broad Institute, who reported that the new approach permits multiplexed gene activation and rapid, large-scale studies of gene function.
You could start with a drug that targets the mutated BRAF along with combination therapy that targets genes that allow the cell to survive. – Silvana Konermann, a graduate student in Dr. Zhang’s lab
Shekhar Suman is a Serial Entrepreneur and the Co-Founder of Biotecnika. Magazine is a way he wants to recraft the way industry opines and expresses its views. With years of experience under his belt, he captains the ship with prudence and perfection. He is the chief-editor of Biotecnika Magazine and a big inspiration to the bio-community.
Your email address will not be published. Required fields are marked *
Notify me of follow-up comments by email.
Notify me of new posts by email.
2014 Powered By Wordpress, Goodnews Theme By Momizat Team